Quercetin-phospholipid complex: An amorphous pharmaceutical system in herbal drug delivery

Current Drug Discovery Technologies

Volumn 9, Issue 1, 2012, Pages 17-24

  Singh, Devendra ^a   Rawat, Mohan S M ^a   Semalty, Ajay ^a   Semalty, Mona ^a  

^a H N B GARHWAL UNIVERSITY   (India)

Author keywords

Amorphous product; Antioxidant activity; Phosphatidylcholine; Phospholipid complex; Quercetin; Solubility behavior

Indexed keywords

PHOSPHOLIPID; QUERCETIN; WATER;

ANTIOXIDANT ACTIVITY; AQUEOUS SOLUTION; ARTICLE; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; GASTROINTESTINAL ABSORPTION; IN VITRO STUDY; INFRARED SPECTROSCOPY; PHYSICAL CHEMISTRY; POROSITY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; X RAY POWDER DIFFRACTION;

ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; PHOSPHATIDYLCHOLINES; QUERCETIN; SOLUBILITY;

EID: 84858267405     PISSN: 15701638     EISSN: 18756220     Source Type: Journal    
DOI: 10.2174/157016312799304507     Document Type: Article

References (38)

1. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004; 79(5): 727-47. (Pubitemid 41103873)
2. Yue PF, Yuan HL, Xie H, et al. Preparation, characterization, and bioavailability of ursodeoxycholic acid-phospholipid complex In vivo. Drug Dev Ind Pharm 2008; 34(7): 708-18. (Pubitemid 351965485)
3. Bombardelli E, Curri SB, Della Loggia R, Del Negro P, Tubaro A, Gariboldi P. Complex between phospholipids and vegetal derivatives of biological interest. Fitoterapia 1989; 60(1): 1-9.
4. Semalty A, Semalty M, Rawat BS, Singh D, Rawat MSM. Pharmacosomes: the lipid based novel drug delivery system. Expert Opin Drug Deliv 2009; 6(6): 599-612.
5. Miean KH, Mohamed S. Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J Agric Food Chem 2001; 49(6): 3106-12. (Pubitemid 32826116)
6. Abad MJ, Bermejo P, Villar A, Valverde S. Anti-inflammatory activity of two flavonoids from tanacetum microphyllum. J Nat Prod 1993; 56: 1164-7. (Pubitemid 23222217)
7. Verma AK, Johnson JA, Gould MN, Tanner MA. Inhibition of 7,12-Dimethyle(α)anthracene and N-nitrosomethyleurea-induced rat mammary cancer by dietary flavonol quercetin. Cancer Res 1988; 48: 5754-8.
8. Lamson DW, Brignall MS. Antioxidants and cancer III: Quercetin. Altern Med Rev 2000; 5(3): 196-208. (Pubitemid 30419042)
9. Adel AKE, Amira AS, Hanan MAE, Nagwa IS. Protective effect of taurine and quercetin against renal dysfunction associated with the combined use of gemtamycin and diclofenac. Indian J Biochem Biophys 2008; 45: 332-40.
10. Heo HJ, Lee CY. Protective effects of quercetin and vitamin C against oxidative stress-induced neurodegeration. J Agric Food Chem 2004; 52: 7514-7.
11. Edwards RL, Lyon T, Litwin SE, Rabovsky A, Symons JD, Jalili T. Quercetin reduces blood pressure in hypertensive subjects. J Nutrition 2007; 137: 2405-11. (Pubitemid 350058708)
12. Leuner C, Dressmann J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2002; 54: 107-12.
13. Rabinow BE. Nanosuspension in drug delivery. Nat Rev Drug Discov 2004; 3: 785-96.
14. Patravale VB, Date AA, Kulkarni RM. Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol 2004; 56: 827-40. (Pubitemid 38885975)
15. Kesisoglon F, Panmai S, Wu Y. Nanosizing oral formulation development and biopharmaceutical evaluation. Adv Drug Dev Rev 2007; 59: 63-644.
16. Nijlen TV, Brennan K, Mooter VG, Blaton N, Kinget R, Augustijns P. Improvement of the dissolution rate of artemisinin by means of supercritical fluid technology and solid dispersions. Int J Pharm 2003; 254: 173-81. (Pubitemid 36298826)
17. Nokhodchi A. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts. J Pharm Pharm Sci 2005; 8: 18-25. (Pubitemid 41528866)
18. Yanyu X, Yunmei S, Zhipeng C, Qineng P. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm 2006; 307: 77-82. (Pubitemid 41773254)
19. Imai T, Shiraishi S, Saito H, Otagiri M. Interaction of indomethacin with low molecular weight chitosan, and improvements of some pharmaceutical properties of indomethacin by low molecular weight chitosans. Int J Pharm 1991; 67: 11-20.
20. Zhang M, Li XH, Gong YD, Zhao NM, Zhang XF. Properties and biocompatibility of chitosan films modified by blending with PEG. Biomaterials 2002; 23: 2641-8. (Pubitemid 34465727)
21. Cai K, Rechtenbachb A, Haoa J, Bosserta J, Jandt KD. Polysaccharide protein surface modification of titanium via a layer-by-layer technique: characterization and cell behavior aspects. Biomaterials 2005; 26: 5960-71. (Pubitemid 40812362)
22. Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 2007; 330(1-2): 155-63. (Pubitemid 46097368)
23. Semalty A, Semalty M, Rawat MSM, Federico F. Supramolecular phospholipids-polyphenolic interactions: the PHYTOSOME®strategy to improve the bioavailability of phytochemicals. Fitoterapia 2010; 81: 306-14.
24. Bombardelli E, Patri GF. Complex compounds of bioflavonoids with phospholipids, their preparation and use and pharmaceutical and cosmetic compositions containing them. US Patent 5,043,323, 1991.
25. Kidd PM. Phosphatidylcholine: a superior protectant against liver damage. Altern Med Rev 1996; 1(4): 258-74. (Pubitemid 126737426)
26. Blois MS. Antioxidant determination by the use of a stable free radical. Nature 1958; 181: 1199-200.
27. Semalty M, Semalty A, Rawat BS, Singh D, Joshi GP, Rawat MSM. In vitro anti-oxidant activity of Garanium wallichianum (laljari). The Indian Pharmacist 2009; 8(No. 87): 94-96.
28. Semalty A, Semalty M, Singh D, Rawat MSM. Preparation and characterization of phospholipid complexes of naringenin for effective drug delivery. J Incl Phenom Macrocycl Chem 2010; 67(3): 253-60.
29. Semalty A, Semalty M, Singh D, Rawat MSM. Development and physicochemical evaluation of pharmacosomes of diclofenac. Acta Pharm 2009; 59: 335-44.
30. Kapoor A, Mujumdar DK, Yadav MR. Crystal forms of nimesulide-a sulfonanilide (non-steroidal anti-inflammatory drug). Indian J Chemistry- Section B Organic and Medicinal Chemistry 1998; 37(6): 572-5. (Pubitemid 128485858)
31. Paradkar AR, Pawar AP, Chordiya JK, Patil VB, Ketkar AR. Spherical crystallization of celecoxib. Drug Dev Ind Pharm 2002; 28: 1213-20. (Pubitemid 35416650)
32. Nagapudi K, Jona J. Amorphous active pharmaceutical ingredients in preclinical studies: preparation, characterization and formulation. Current Bioactive Compounds 2008; 4: 213-24.
33. Babu GVMM, Prasad CDS, Murthy KVR. Evaluation of modified gum karaya as carrier for the dissolution enhancement of poorly water soluble drug nimodipine. Int J Pharm 2002; 234: 1-17.
34. Moneghini M, Kikie I, Voinovich D, Perissutti B, Grcic JF. Processing of carbamazepine-PEG 4000 solid dispersions with supercritical carbon dioxide: preparation, characterization and In vitro dissolution. Int J Pharm 2001; 222: 129-38. (Pubitemid 32525794)
35. Papageorgiou GZ, Papadimitriou S, Karavas E, Georgarakis E, Docoslis A, Bikiaris D. Improvement in chemical and physical stability of fluvastatin drug through hydrogen bonding interactions with different polymer matrices. Curr Drug Deliv 2009; 6(1): 101-12.
36. Craig DQM, Royall PG, Kett VL, Hopton ML. The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems. Int J Pharm 1999; 179: 179-207. (Pubitemid 29131430)
37. Hancock BC, Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 1997; 86: 1-12.
38. Rothwell JA, Day AJ, Morgan MR. Experimental determination of octanol-water partition coefficients of quercetin and related flavonoids. J Agric Food Chem 2005; 53(11): 4355-60. (Pubitemid 40855457)